SHARE THIS COMPANY
Defymed® is a company that develops implantable bio-artificial medical devices for diverse therapeutic applications. Our blockbuster product is a bio-artificial pancreas, named MAILPAN (MAcro-encapsulation of PANcreatic Islets) to treat type 1 diabetic patients, for which a first functional and mechanical validation have been performed. Products under investigation will target other therapies such as for liver (bioartificial liver) and kidney diseases (bioartificial kidney).
+ Read more
Related activities :
Consumer Goods and Healthcare
>> Biotechnology, Pharmaceuticals
Export area :
European Union
>> France
Local presence :
Target countries :
>> Belgium
>> Germany
>> Italy
>> Spain
>> United Kingdom
North America
>> Canada
>> Mexico
>> United States
Oceania
>> Australia
>> New Zealand
More information